These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24587329)

  • 21. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.
    Yi M; Ma Y; Yates J; Lemon SM
    PLoS Pathog; 2009 May; 5(5):e1000403. PubMed ID: 19412343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proprotein convertase subtilisin/kexin type 9 inhibits hepatitis C virus replication through interacting with NS5A.
    Li Z; Liu Q
    J Gen Virol; 2018 Jan; 99(1):44-61. PubMed ID: 29235977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.
    Scheel TK; Gottwein JM; Mikkelsen LS; Jensen TB; Bukh J
    Gastroenterology; 2011 Mar; 140(3):1032-42. PubMed ID: 21111742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
    Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.
    Boukadida C; Marnata C; Montserret R; Cohen L; Blumen B; Gouttenoire J; Moradpour D; Penin F; Martin A
    J Virol; 2014 Jul; 88(13):7426-44. PubMed ID: 24741107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses.
    Sun HY; Ou NY; Wang SW; Liu WC; Cheng TF; Shr SJ; Sun KT; Chang TT; Young KC
    PLoS One; 2011; 6(9):e25530. PubMed ID: 21980483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly.
    Popescu CI; Callens N; Trinel D; Roingeard P; Moradpour D; Descamps V; Duverlie G; Penin F; Héliot L; Rouillé Y; Dubuisson J
    PLoS Pathog; 2011 Feb; 7(2):e1001278. PubMed ID: 21347350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication.
    Shanmugam S; Saravanabalaji D; Yi M
    J Virol; 2015 Apr; 89(8):4562-74. PubMed ID: 25673706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
    Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
    Molecules; 2017 May; 22(5):. PubMed ID: 28531161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
    Chukkapalli V; Berger KL; Kelly SM; Thomas M; Deiters A; Randall G
    Virology; 2015 Feb; 476():168-179. PubMed ID: 25546252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Itsui Y; Sakamoto N; Kakinuma S; Nakagawa M; Sekine-Osajima Y; Tasaka-Fujita M; Nishimura-Sakurai Y; Suda G; Karakama Y; Mishima K; Yamamoto M; Watanabe T; Ueyama M; Funaoka Y; Azuma S; Watanabe M
    Hepatology; 2009 Dec; 50(6):1727-37. PubMed ID: 19821486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor.
    Lin HM; Wang JC; Hu HS; Wu PS; Yang CC; Wu CP; Pu SY; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yeh TK; Yueh A
    Antimicrob Agents Chemother; 2012 Jan; 56(1):44-53. PubMed ID: 22006008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
    Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
    J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoprotease.
    Shaw J; Harris M; Fishwick CW
    Antiviral Res; 2015 Dec; 124():54-60. PubMed ID: 26518228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture.
    Aus dem Siepen M; Lohmann V; Wiese M; Ross S; Roggendorf M; Viazov S
    Virology; 2005 Jun; 336(2):131-6. PubMed ID: 15892954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity and resistance of HCV NS5A replication complex inhibitors.
    Gao M
    Curr Opin Virol; 2013 Oct; 3(5):514-20. PubMed ID: 23896281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.